| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744737 | Clinical Microbiology and Infection | 2018 | 8 Pages |
Abstract
EFV-TDF-FTC showed significantly greater increases in CD4/CD8 ratio â¥1.0 or MTMR beyond treatment week 96. Additional studies are necessary to better understand the impact of these findings.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
J.R. Blanco, B. Alejos, S. Moreno,